Chhetri Sunit, Manandar Srista, Chhetri Sunny, Acharya Astha, Regmi Swapnil, Gurudhami Dil Bahadur, Dorji Thinley
Department of Internal Medicine B.P. Koirala Institute of Health Sciences Dharan Nepal.
Department of Internal Medicine Central Regional Referral Hospital Gelegphu Bhutan.
Public Health Chall. 2023 Feb 9;2(1):e67. doi: 10.1002/puh2.67. eCollection 2023 Mar.
Nepal, a landlocked country with a population of 29.1 million faced great socioeconomic, financial, and social hardships during the Coronavirus disease 2019 (COVID-19) pandemic. Nepal had increasing cases of COVID-19 despite multiple lockdowns and travel restrictions. Nepal reported 1,000,775 cases and 12,019 deaths till early November 2022. Timely government decisions, strategic political diplomacy, flexible vaccine policy, and multiple loan deals helped Nepal secure the COVID-19 vaccine from India in a commendable time frame. With the existing structure of the primary health care settings and experience of having implemented childhood vaccination campaigns, Nepal rolled out the COVID-19 vaccines across the nation on 27 January 2021. However, the delta wave was a devastating blow to South Asia with a high number of hospitalizations and deaths and a complete disruption of the COVID-19 vaccine supply from India. The government ran a relentless effort in COVID-19 vaccination and provided full vaccination to 33% of the total population by the end of 2021 and 81.1% by May 2022. The booster doses were administered beginning in 2022, but the campaign efforts have been lethargic with a coverage of only 29.2% and a lack of keen support from the public. The emergence of new variants of the virus continues to pose a challenge in controlling the disease and reopening the country to pre-pandemic levels of socioeconomic activities.
尼泊尔是一个内陆国家,人口为2910万,在2019年冠状病毒病(COVID-19)大流行期间面临着巨大的社会经济、财政和社会困境。尽管实施了多次封锁和旅行限制,尼泊尔的COVID-19病例仍不断增加。截至2022年11月初,尼泊尔报告了1000775例病例和12019例死亡。政府及时做出的决策、战略性的政治外交、灵活的疫苗政策以及多项贷款协议,帮助尼泊尔在值得称赞的时间框架内从印度获得了COVID-19疫苗。凭借初级卫生保健机构的现有架构以及实施儿童疫苗接种运动的经验,尼泊尔于2021年1月27日在全国范围内推出了COVID-19疫苗。然而,德尔塔浪潮对南亚造成了毁灭性打击,导致大量住院和死亡,印度的COVID-19疫苗供应也完全中断。政府在COVID-19疫苗接种方面做出了不懈努力,到2021年底为33%的总人口提供了全程接种,到2022年5月这一比例达到了81.1%。加强针接种于2022年开始,但接种工作进展迟缓,接种率仅为29.2%,且缺乏公众的积极支持。病毒新变种的出现继续对控制疫情以及使该国重新开放至疫情前的社会经济活动水平构成挑战。